Daiken Biomedical Co., Ltd.

Research Daiken Biomedical Co., Ltd. (7780.TW) on Bullrun: market cap TWD 12.93B, P/E 160.5, dividend yield 7.3%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is TWD 12.93B; P/E is 160.5; dividend yield is 7.3%.

Peer valuation comparison

Latest P/E is 160.5x versus a Consumer Defensive sector median of 16.8x (855.4% above).

Latest dividend yield is 7.25% versus a Consumer Defensive sector median of 2.98% (143.3% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18TWD 12.93B160.56.8%1.09

Dividend history

Latest trailing dividend snapshot: annual dividend/share 1.09 TWD, yield 7.3%.

YearDividends/share
FY20250.89 TWD

About Daiken Biomedical Co., Ltd.

Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company was founded in 2018 and is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. operates as a subsidiary of Sunfun Info Co., Ltd.

Related stock research

Other Consumer Defensive stocks

Frequently asked questions

What is Daiken Biomedical Co., Ltd.'s market cap?

Daiken Biomedical Co., Ltd.'s market capitalization is TWD 12.93B.

What is Daiken Biomedical Co., Ltd.'s P/E ratio?

Daiken Biomedical Co., Ltd.'s price-to-earnings (P/E) ratio is 160.5.

Does Daiken Biomedical Co., Ltd. pay a dividend?

Daiken Biomedical Co., Ltd. has a dividend yield of 7.3%.

What does Daiken Biomedical Co., Ltd. do?

Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company was founded in 2018 and is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. operates as a subsidiary of Sunfun Info Co., Ltd.